University of Texas/MD Anderson Cancer Center Gastrointestinal Med. Oncology is a clinical research site located in Houston, Texas, United States 77030-4009.
Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.
University of Texas/MD Anderson Cancer Center Gastrointestinal Med. Oncology has participated in 5 clinical trials.
Therapeutic areas: Esophageal Squamous Cell Carcinoma, Advanced Gastric Cancer, Carcinoid Tumor.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Texas/MD Anderson Cancer Center Gastrointestinal Med. Oncology has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Texas/MD Anderson Cancer Center Gastrointestinal Med. Oncology has 5 clinical trials on record. Their work covers Esophageal Squamous Cell Carcinoma, Advanced Gastric Cancer, Carcinoid Tumor.
University of Texas/MD Anderson Cancer Center Gastrointestinal Med. Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.